FierceBiotech ٢٩ مايو ٢٠٢٦ Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed
Thermo Fisher ٢٩ مايو ٢٠٢٦ Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
FDA News Releases ٢٩ مايو ٢٠٢٦ FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
Agilent ٢٩ مايو ٢٠٢٦ Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results - simplywall.st
FierceBiotech ٢٩ مايو ٢٠٢٦ ASCO: BMS’ CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3 myeloma study
FierceBiotech ٢٩ مايو ٢٠٢٦ ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger
FierceBiotech ٢٩ مايو ٢٠٢٦ Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field